Esperion Therapeutics Inc Banner Image

Esperion Therapeutics Inc

  • Ticker ESPR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Esperion Therapeutics Inc Logo Image
  • 11-50 Employees
  • Based in Ann Arbor, Michigan
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. Its products include ETC-1002, an oral molecule therapy that is in Phase 2b clinical trials to treat patientsMore with hypercholesterolemia, as well as to lower levels of LDL-cholesterol, and avoid various side effects associated with LDL-cholesterol lowering therapies.
4.8 / 5.0 (130)

Esperion Therapeutics Inc reports have an aggregate usefulness score of 4.8 based on 130 reviews.

Esperion Therapeutics Inc

Most Recent Annual Report

Esperion Therapeutics Inc
MOST RECENT 2022 Annual Report and Form 10K

Esperion Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Esperion Therapeutics Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!